NO20063430L - Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering - Google Patents
Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administreringInfo
- Publication number
- NO20063430L NO20063430L NO20063430A NO20063430A NO20063430L NO 20063430 L NO20063430 L NO 20063430L NO 20063430 A NO20063430 A NO 20063430A NO 20063430 A NO20063430 A NO 20063430A NO 20063430 L NO20063430 L NO 20063430L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- administration
- rulers
- generally
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Fentanylholdige doseringsformer og fremgangsmåter for anvendelse derav beskrives. Disse doseringsformene omfatter vesentlig mindre fentanyl basert på vekt enn kjente, orale utforminger og har fordeler når det gjelder kostnader og bivirkninger. Disse doseringsformene er beregnet for oral tilførsel av fentanyl over de orale slimhinner.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53361903P | 2003-12-31 | 2003-12-31 | |
US61566504P | 2004-10-04 | 2004-10-04 | |
PCT/US2004/043703 WO2005065319A2 (en) | 2003-12-31 | 2004-12-30 | Generally linear effervescent oral fentanyl dosage form and methods of administering |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20063430L true NO20063430L (no) | 2006-09-15 |
NO338714B1 NO338714B1 (no) | 2016-10-03 |
Family
ID=34753002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063430A NO338714B1 (no) | 2003-12-31 | 2006-07-25 | Generelt lineær, brusende, oral fentanyl doseringsform som er egnet for administrering av fentanyl over en pasients orale slimhinner ved bukkal, gingival eller sublingval administrering, og fremgangsmåter for fremstilling derav. |
Country Status (23)
Country | Link |
---|---|
US (3) | US20050142197A1 (no) |
EP (1) | EP1708686B1 (no) |
JP (2) | JP2007517054A (no) |
KR (1) | KR101184138B1 (no) |
CN (1) | CN102078310B (no) |
AT (1) | ATE498395T1 (no) |
AU (1) | AU2004311880B2 (no) |
BR (1) | BRPI0418228B8 (no) |
CA (1) | CA2548915C (no) |
CY (1) | CY1111458T1 (no) |
DE (1) | DE602004031462D1 (no) |
DK (1) | DK1708686T3 (no) |
EA (1) | EA010826B1 (no) |
HK (1) | HK1100480A1 (no) |
HR (1) | HRP20110336T1 (no) |
IL (1) | IL176449A (no) |
ME (1) | ME01300B (no) |
NO (1) | NO338714B1 (no) |
NZ (1) | NZ548216A (no) |
PL (1) | PL1708686T3 (no) |
PT (1) | PT1708686E (no) |
RS (1) | RS51713B (no) |
WO (1) | WO2005065319A2 (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
EP2295043A1 (en) | 1999-10-29 | 2011-03-16 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
AU2738302A (en) | 2000-10-30 | 2002-05-15 | Euro Celtique Sa | Controlled release hydrocodone formulations |
US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
JP5244318B2 (ja) * | 2003-12-31 | 2013-07-24 | シーマ・ラブス、インコーポレイテッド | 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法 |
WO2005065319A2 (en) | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US7858121B2 (en) | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
KR20130006523A (ko) | 2004-02-17 | 2013-01-16 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법 |
US20060276501A1 (en) * | 2005-05-25 | 2006-12-07 | Transoral Pharmaceuticals, Inc. | Solid compositions for treating middle-of-the-night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
US20070020186A1 (en) * | 2005-07-22 | 2007-01-25 | Alpex Pharma S.A. | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
US20070104763A1 (en) * | 2005-11-10 | 2007-05-10 | Navinta Llc | Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8252328B2 (en) * | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8202535B2 (en) * | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8252329B2 (en) * | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8865743B2 (en) * | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US20070260491A1 (en) * | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
US20080090874A1 (en) * | 2006-09-20 | 2008-04-17 | Messina John C Jr | Treatment of breakthrough pain in patients suffering from chronic low back pain |
US20080132535A1 (en) * | 2006-11-30 | 2008-06-05 | Transcept Pharmaceuticals, Inc. | Stabilized Zolpidem Pharmaceutical Compositions |
MX2009005671A (es) * | 2006-12-01 | 2009-06-08 | Cima Labs Inc | Forma de dosificacion de nicotina transmucosal oral. |
US20090214442A1 (en) * | 2006-12-01 | 2009-08-27 | Cephalon, Inc. | Oral Transmucosal Nicotine Dosage Form |
AU2008216867B2 (en) * | 2007-02-09 | 2014-01-30 | Durect Corporation | Transoral dosage forms comprising sufentanil and naloxone |
WO2008133952A2 (en) * | 2007-04-24 | 2008-11-06 | Cephalon, Inc. | Transmucosal treatment with fentanyl in patients with mucositis |
MX2009011784A (es) | 2007-05-01 | 2009-11-13 | Cephalon Inc | Composicion para el suminitro transmucosal de polipeptidos. |
ES2635137T3 (es) * | 2007-08-07 | 2017-10-02 | Acelrx Pharmaceuticals, Inc. | Formas de dosificación oral transmucosal que comprenden sufentanilo y triazolam |
ITMI20071971A1 (it) * | 2007-10-10 | 2009-04-11 | Altergon Sa | Composizione farmaceutica per la somministrazione sublinguale di progesterone, e metodo per la sua preparazione |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
MX336355B (es) | 2009-03-04 | 2016-01-14 | Orexo Ab | Formulacion resistente al abuso. |
US9486527B2 (en) * | 2009-05-08 | 2016-11-08 | Emplicure Ab | Composition for sustained drug delivery comprising geopolymeric binder |
MX2012012991A (es) | 2010-05-11 | 2012-11-30 | Cima Labs Inc | Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol. |
DK2613784T3 (da) | 2010-09-07 | 2018-01-29 | Emplicure Ab | Indretning til transdermal indgivelse af lægemiddel |
US9320526B1 (en) * | 2011-10-13 | 2016-04-26 | Enteroptyx | Punctum plug |
RS57951B1 (sr) | 2012-05-02 | 2019-01-31 | Orexo Ab | Nova kompozicija alfentanila za tretman akutnog bola |
WO2014145285A1 (en) * | 2013-03-15 | 2014-09-18 | Mylan Inc. | Manufacturing process for effervescent dosage forms |
SG11201704797TA (en) | 2014-12-23 | 2017-07-28 | Acelrx Pharmaceuticals Inc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
NO20171457A1 (no) * | 2016-12-20 | 2018-06-21 | X Ing As | Effervesent sugetablett |
WO2018117855A1 (en) * | 2016-12-20 | 2018-06-28 | X-Ing As | Effervescent lozenge |
Family Cites Families (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1262888A (en) * | 1917-02-20 | 1918-04-16 | Albert Westlake | Mouth-tablet. |
US1263888A (en) * | 1918-01-10 | 1918-04-23 | J T Vail | Wave-motor. |
US2887437A (en) | 1956-08-22 | 1959-05-19 | Pfizer & Co C | Palatable vitamin tablet containing an amino acid |
US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
US3042531A (en) | 1959-12-09 | 1962-07-03 | Leslie Salt Company | Method of making a compressed tablet |
US3577490A (en) * | 1967-10-02 | 1971-05-04 | Miles Lab | Effervescent tablet and process for making same |
GB1212704A (en) | 1967-11-21 | 1970-11-18 | Prodotti Antibiotici Spa | Vaginal suppositories |
US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
NL7302521A (en) | 1973-02-23 | 1974-08-27 | Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use | |
US3962417A (en) * | 1974-03-27 | 1976-06-08 | Howell Charles J | Dentifrice |
JPS5157813A (en) * | 1974-11-14 | 1976-05-20 | Sankyo Co | Ll dooba mataha sonojudotaiseizaino seiho |
US3972995A (en) * | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
US4147768A (en) * | 1976-09-13 | 1979-04-03 | Interx Research Corporation | Enteric coated digoxin and therapeutic use thereof |
US4370160A (en) | 1978-06-27 | 1983-01-25 | Dow Corning Corporation | Process for preparing silicone microparticles |
US4187286A (en) * | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
JPS58152809A (ja) * | 1982-03-05 | 1983-09-10 | Eisai Co Ltd | 安定な発泡性「膣」坐剤 |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
US4599342A (en) * | 1984-01-16 | 1986-07-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
GB8410290D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
US4613497A (en) * | 1984-02-29 | 1986-09-23 | Health Products Development, Inc. | Dry, water-foamable pharmaceutical compositions |
US4725427A (en) * | 1984-03-13 | 1988-02-16 | Albion International, Inc. | Effervescent vitamin-mineral granule preparation |
US4863737A (en) * | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
GB8421226D0 (en) * | 1984-08-21 | 1984-09-26 | Int Conferences Ab | Tooth cleaning tablet |
US4639368A (en) * | 1984-08-23 | 1987-01-27 | Farmacon Research Corporation | Chewing gum containing a medicament and taste maskers |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4756710A (en) * | 1985-04-05 | 1988-07-12 | Merck & Co., Inc. | pH-Mediated drug delivery system |
US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
US5785989A (en) * | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
US5288497A (en) | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
US4687662A (en) * | 1985-08-30 | 1987-08-18 | Warner-Lambert Company | Therapeutic effervescent composition |
US5053396A (en) * | 1985-08-27 | 1991-10-01 | Blass David H | Therapeutic composition |
US4764375A (en) | 1985-09-11 | 1988-08-16 | Kv Pharmaceutical Company | Sachet drug delivery system |
IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
US4876039A (en) | 1986-11-04 | 1989-10-24 | Dow Corning Corporation | Process for preparing silicone microparticles cured by a Michael addition reaction |
IE873172L (en) | 1986-12-29 | 1988-06-29 | Harvard College | Continuous process for producing a comestible tablet |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
FR2633181B1 (fr) | 1988-06-24 | 1992-01-10 | Glaxo Lab Sa | Composition pharmaceutique a base de ranitidine et son procede de preparation |
GB8820327D0 (en) | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
US5135752A (en) * | 1988-10-14 | 1992-08-04 | Zetachron, Inc. | Buccal dosage form |
US5004601A (en) * | 1988-10-14 | 1991-04-02 | Zetachron, Inc. | Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
US5002771A (en) * | 1989-02-06 | 1991-03-26 | Rorer Pharmaceutical Corp. | Calcitonin suppository formulations |
GB8909793D0 (en) | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5102666A (en) * | 1990-09-11 | 1992-04-07 | Oramed, Inc. | Calcium polycarbophil controlled release composition and method |
US5468504A (en) * | 1990-12-21 | 1995-11-21 | Laboratoires Glaxo S.A. | Effervescent pharmaceutical compositions |
TW212139B (no) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
AU665188B2 (en) * | 1991-04-15 | 1995-12-21 | Applied Microbiology, Inc | Pharmaceutical compositions against gastric disorders |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
IT1251114B (it) | 1991-07-26 | 1995-05-04 | Farcon Ag | Forme farmaceutiche antivirali per applicazione vaginale |
DE4139883A1 (de) | 1991-11-29 | 1993-06-03 | Michael Prof Dr Dittgen | Verfahren zur herstellung bioadhaesiver arzneimittel |
IT1253711B (it) * | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
DE69331839T2 (de) * | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries, Ltd. | Schnellösliche Tablette und ihre Herstellung |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US5851553A (en) | 1993-09-10 | 1998-12-22 | Fuisz Technologies, Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5635210A (en) | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
CA2183083C (en) * | 1994-03-07 | 2006-01-03 | Charles D. Ebert | Drug-containing adhesive composite transdermal delivery device |
JP4157969B2 (ja) * | 1994-03-18 | 2008-10-01 | スパーナス ファーマシューティカルズ インコーポレイテッド | 乳化薬物送達システム |
WO1995028144A1 (en) * | 1994-04-13 | 1995-10-26 | Ciba-Geigy Ag | Temporally controlled drug delivery systems |
US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
US5550861A (en) * | 1994-09-27 | 1996-08-27 | Novalink Technologies, Inc. | Modular PCMCIA modem and pager |
CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
FR2729858B1 (fr) | 1995-01-30 | 1997-04-18 | Mission Soc Civ | Composition effervescente a base de polyvinylpyrrolidone iodee et utilisation pour la desinfection |
FR2732217B1 (fr) | 1995-03-29 | 1997-06-06 | Hesnard Xavier | Forme d'administration solide a usage oral |
US5656284A (en) * | 1995-04-24 | 1997-08-12 | Balkin; Michael S. | Oral transmucosal delivery tablet and method of making it |
GB9510830D0 (en) * | 1995-05-27 | 1995-07-19 | Zeneca Ltd | Proteins |
US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
CA2218370C (en) | 1995-07-31 | 2006-10-03 | Gerhard Gergely | Chewable tablet with effervescent action |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
AU707646B2 (en) * | 1995-11-06 | 1999-07-15 | Somerset Pharmaceuticals, Inc. | Sublingual and buccal administration of selegiline |
GB9523136D0 (en) * | 1995-11-11 | 1996-01-10 | Procter & Gamble | Silicone-containing powders |
GB2307857B (en) | 1995-12-04 | 1999-01-27 | Euro Celtique Sa | An effervescent formulation |
US5958455A (en) * | 1996-02-09 | 1999-09-28 | Quadrant Holdings Cambridge Ltd | Oral solid dosage forms, methods of making same and compositions thereof |
DE19606151C2 (de) * | 1996-02-20 | 1999-05-12 | Losan Pharma Gmbh | Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben |
US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
DE19618543C2 (de) * | 1996-05-08 | 1998-07-02 | Ivoclar Ag | Polymerisationsgerät |
ES2210529T3 (es) | 1996-05-17 | 2004-07-01 | MERCK & CO., INC. | Formulacion de bisfosfonato efervescente. |
US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
US6488961B1 (en) * | 1996-09-20 | 2002-12-03 | Ethypharm, Inc. | Effervescent granules and methods for their preparation |
US20010006677A1 (en) * | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
CA2284132C (en) | 1997-04-01 | 2004-09-07 | Cima Labs Inc. | Blister package and packaged tablet |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
ES2173364T5 (es) * | 1997-10-27 | 2005-04-16 | DR. GERGELY & CO. | Composicion efervescente con extracto vegetal. |
US6326360B1 (en) * | 1998-03-11 | 2001-12-04 | Grelan Pharmaceuticals Co., Ltd. | Bubbling enteric coated preparations |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6576250B1 (en) * | 1998-03-27 | 2003-06-10 | Cima Labs Inc. | Pharmaceutical compositions for rectal and vaginal administration |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
DE19814257A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
US6368625B1 (en) * | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
SE9803240D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6680071B1 (en) | 1999-03-03 | 2004-01-20 | R. P. Scherer Technologies, Inc. | Opioid agonist in a fast dispersing dosage form |
US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6326384B1 (en) * | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US6262062B1 (en) * | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
WO2002045713A2 (en) * | 2000-12-04 | 2002-06-13 | Sepracor, Inc. | Orally-bioavailable formulations of fentanyl and congeners thereof |
US20030068356A1 (en) | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
FR2832311B1 (fr) * | 2001-11-21 | 2004-04-16 | Besins Int Belgique | Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations |
FR2834212B1 (fr) * | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
US6713470B2 (en) * | 2002-01-22 | 2004-03-30 | Ml Laboratories Plc | Method of treatment |
PL211224B1 (pl) | 2003-01-31 | 2012-04-30 | Orexo Ab | Kompozycja farmaceutyczna do leczenia ostrych zaburzeń przez podjęzykowe lub donosowe podawanie oraz jej zastosowanie |
US20050042281A1 (en) | 2003-08-21 | 2005-02-24 | Singh Nikhilesh N. | Compositions for delivering therapeutic agents across the oral mucosa |
US7858121B2 (en) * | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
WO2005065319A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US20070036853A1 (en) * | 2003-12-31 | 2007-02-15 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
JP5244318B2 (ja) | 2003-12-31 | 2013-07-24 | シーマ・ラブス、インコーポレイテッド | 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法 |
TWI387466B (zh) | 2004-10-04 | 2013-03-01 | Cima Labs Inc | 一般線型起泡的口服吩坦尼(fentanyl)劑型及投藥方法 |
-
2004
- 2004-12-30 WO PCT/US2004/043703 patent/WO2005065319A2/en active Application Filing
- 2004-12-30 EA EA200601253A patent/EA010826B1/ru not_active IP Right Cessation
- 2004-12-30 US US11/026,327 patent/US20050142197A1/en not_active Abandoned
- 2004-12-30 PL PL04815716T patent/PL1708686T3/pl unknown
- 2004-12-30 CN CN2011100059711A patent/CN102078310B/zh active Active
- 2004-12-30 NZ NZ548216A patent/NZ548216A/en active IP Right Revival
- 2004-12-30 ME MEP-2011-87A patent/ME01300B/me unknown
- 2004-12-30 PT PT04815716T patent/PT1708686E/pt unknown
- 2004-12-30 CA CA2548915A patent/CA2548915C/en active Active
- 2004-12-30 KR KR1020067015392A patent/KR101184138B1/ko active IP Right Grant
- 2004-12-30 AT AT04815716T patent/ATE498395T1/de active
- 2004-12-30 DE DE602004031462T patent/DE602004031462D1/de active Active
- 2004-12-30 AU AU2004311880A patent/AU2004311880B2/en active Active
- 2004-12-30 US US11/026,132 patent/US7862832B2/en active Active
- 2004-12-30 DK DK04815716.8T patent/DK1708686T3/da active
- 2004-12-30 RS RS20110186A patent/RS51713B/en unknown
- 2004-12-30 BR BRPI0418228A patent/BRPI0418228B8/pt active IP Right Grant
- 2004-12-30 JP JP2006547499A patent/JP2007517054A/ja not_active Withdrawn
- 2004-12-30 EP EP04815716A patent/EP1708686B1/en active Active
-
2006
- 2006-06-20 IL IL176449A patent/IL176449A/en active IP Right Grant
- 2006-07-25 NO NO20063430A patent/NO338714B1/no unknown
-
2007
- 2007-05-29 HK HK07105659.4A patent/HK1100480A1/xx unknown
-
2010
- 2010-11-29 US US12/955,229 patent/US8092832B2/en active Active
-
2011
- 2011-05-06 HR HR20110336T patent/HRP20110336T1/hr unknown
- 2011-05-16 CY CY20111100466T patent/CY1111458T1/el unknown
-
2013
- 2013-02-07 JP JP2013022495A patent/JP5685610B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063430L (no) | Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering | |
WO2005065317A3 (en) | Effervescent oral fentanyl dosage form | |
ZA200606173B (en) | Effervescent oral opiate dosage form | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
NO20043998L (no) | Oral administreringsform for tungtloselige basiske aktive virkestoffer | |
WO2005115406A3 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
SE0301700D0 (sv) | Novel compounds | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
ITMI20031570A1 (it) | Composizione per uso dietetico, farmaceutico o cosmetico | |
NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
TW200509992A (en) | Dosage form containing pantoprazole as active ingredient | |
ITMI20022777A1 (it) | Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. | |
TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
SE0300457D0 (sv) | Novel compounds | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
SE0203817D0 (sv) | New composition | |
ITRM20020119A0 (it) | Composizioni contenenti plgf ad uso farmaceutico e cosmetico. | |
TW200611696A (en) | Effervescent oral fentanyl dosage form and methods of administering fentanyl | |
TW200611686A (en) | Effervescent oral opiate dosage forms and methods of administering opiates |